Charles Schwab Investment Advisory, Inc. Abbott Laboratories Transaction History

Charles Schwab Investment Advisory, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $217,307 - $262,654	-2,129 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $242,748 - $296,016	2,129 New	2,129 $252,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $225 Million - $329 Million	-3,582,479 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $6.57 Million - $7.32 Million	83,709 Added 2.39%	3,582,479 $311 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $1.08 Million - $1.17 Million	13,142 Added 0.38%	3,498,770 $293 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $27.5 Million - $32 Million	-376,687 Reduced 9.75%	3,485,628 $293 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $34.3 Million - $41.5 Million	-518,035 Reduced 11.83%	3,862,315 $309 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $7.36 Million - $8.33 Million	-112,217 Reduced 2.5%	4,380,350 $317 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $1.69 Million - $2.04 Million	-27,799 Reduced 0.61%	4,492,567 $330 Million
Q2 2018 Aug 09, 2018	BUY	$57.57 - $63.54 $260 Million - $287 Million	4,520,366 New	4,520,366 $276 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Advisory, Inc., based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Advisory, Inc. with notifications on news.